Overall survival and self-reported fatigue in patients with esophageal cancer

Supportive Care in Cancer

Volumn 21, Issue 2, 2013, Pages 511-519

  Stauder, M C ^a   Romero, Y ^a   Kabat, B ^a   Atherton, P J ^a   Geno, D ^a   Deschamps, C ^a   Jatoi, A ^a   Sloan, J A ^a   Botros, M ^a   Jung, K W ^b   Arora, A S ^a   Miller, R C ^a  

^a MAYO CLINIC   (United States)

^b Asan Medical Center   (South Korea)

Author keywords

Barrett esophagus; Comparative study; Esophageal neoplasms; Quality of life; Survival; Survivorship

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; DECREASED ENERGY LEVEL; ENERGY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; LINEAR ANALOG SELF ASSESSMENT FATIGUE SCORE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NORMAL ENERGY LEVEL; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SELF REPORT; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGISTRIES; SICKNESS IMPACT PROFILE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84874115276     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1537-1     Document Type: Article

References (41)

1. Jemal A, Siegel R, Xu JQ, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
2. Blazeby JM, Williams MH, Brookes ST, Alderson D, Farndon JR (1995) Quality-of-life measurement in patients with esophageal cancer. Gut 37:505-508
3. Van Meerten E, Van Der Gaast A, Looman CWN, Tilanus HWG, Muller K, Essink-Bot ML (2008) Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys 71:160-166
4. Watt E, Whyte F (2003) The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer. Eur J Cancer Care 12:183-193
5. Gaast AV, van Hagen P, Hulshof M, Richel D, van Berge Henegouwen MI, Nieuwenhuijzen GA, Plukker JT, Bonenkamp JJ, Steyerberg EW, Tilanus HW, CROSS Study Group (2010) Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study. ASCO Meeting Abstracts 28: 4004
6. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Langer P, Engenhart-Cabillic R, Bitzer M, Konigsrainer A, Budach W, Wilke H (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851-856
7. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086-1092
8. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467
9. Bergquist H, Johnsson A, Hammerlid E, Wenger U, Lundell L, Ruth M (2008) Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation. Aliment Pharmacol Ther 27:385-395
10. Blazeby JM, Brookes ST, Alderson D (2001) The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 49:227-230
11. Coates A, Porzsolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33:1025-1030
12. Djarv T, Metcalfe C, Avery KNL, Lagergren P, Blazeby JM (2010) Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. J Clin Oncol 28:1666-1670
13. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY (2004) Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 58:1394-1404
14. Frost MH, Sloan JA (2002) Quality of life measurements: a soft outcome - or is it? Am J Manag Care 8:S574-S579
15. Healy LA, Ryan AM, Moore J, Rowley S, Ravi N, Byrne PJ, Reynolds JV (2008) Health-related quality of life assessment at presentation may predict complications and early relapse in patients with localized cancer of the esophagus. Dis Esophagus 21:522-528
16. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 38:1351-1357
17. Mauer M, Stupp R, Taphoorn MJB, Coens C, Osoba D, Marosi C, Wong R, de Witte O, Cairncross JG, Efficace F, Mirimanoff RO, Forsyth P, van den Bent MJ, Weller M, Bottomley A (2007) The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 97:302-307
18. McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC (2008) The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 98:888-893
19. Qi YW, Schild SE, Mandrekar SJ, Tan AD, Krook JE, Rowland KM, Garces YI, Soori GS, Adjei AA, Sloan JA (2009) Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol 4:1075-1082
20. Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Roenn JH, Carro G, Straus JL, Muir JC, Cella D (2008) Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 35:20-30
21. Locke DEC, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer PL, Buckner JC (2007) Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage 34:628-638
22. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C (2002) Clinical significance consensus M: assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 77:479-487
23. Grunberg SM, Groshen S, Steingass S, Zaretsky S, Meyerowitz B (1996) Comparison of conditional quality of life terminology and visual analogue scale measurements. Qual Life Res 5:65-72
24. Gudex C, Dolan P, Kind P, Williams A (1996) Health state valuations from the general public using the visual analogue scale. Qual Life Res 5:521-531
25. Hyland ME, Sodergren SC (1996) Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales. Qual Life Res 5:469-480
26. Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G (1983) Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 34:234-239
27. Wewers ME, Lowe NK (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13:227-236
28. Sloan JA, Liu H, Sargent DJ, Satele D, Schaefer PL, Halyard MY, Grothey A, Garces YI, Brown PD, Loprinzi CL, Buckner JC (2009) A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. ASCO Meeting Abstracts 27:9599
29. Tan AD, Novotny PJ, Kaur JS, Buckner JC, Schaefer PL, Stella PJ, Kuebler JP, Sloan JA (2008) A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. ASCO Meeting Abstracts 26: 9515
30. Gockel I, Gonner U, Domeyer M, Lang H, Junginger T (2010) Long-term survivors of esophageal cancer: disease-specific quality of life, general health and complications. J Surg Oncol 102:516-522
31. Teoh AYB, Chiu PWY, Wong TCL, Liu SYW, Wong SKH, Ng EKW (2011) Functional performance and quality of life in patients with squamous esophageal carcinoma receiving surgery or chemoradiation results from a randomized trial. Ann Surg 253:1-5
32. Hurmuzlu M, Aarstad HJ, Aarstad AKH, Hjermstad MJ, Viste A (2011) Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer. Dis Esophagus 24:39-47
33. Miller RC, Atherton PJ, Kabat BF, Fredericksen MB, Geno DM, Deschamps C, Jatoi A, Sloan JA, Romero Y (2010) Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Study. Dig Dis Sci 55:2860-2868
34. Greene RLPD, Fleming ID (2002) AJCC cancer staging manual, 6th edn. Springer, New York
35. Flechtner H, Bottomley A (2003) Fatigue and quality of life: lessons from the real world. Oncologist 8:5-9
36. Lagarde SM, ten Kate FW, Reitsma JB, Busch ORC, van Lanschot JJB (2006) Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 24:4347-4355
37. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Dehaes J, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European-Organization-for-Research-and-Treatment-of-Cancer QLQ-C30 - a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
38. Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, Cleeland C, Osoba D, Bjordal K, Bottomley A, Grp EC (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10:865-871
39. Blazeby JM, Metcalfe C, Nicklin J, Barham CP, Donovan J, Alderson D (2005) Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. Br J Surg 92:1502-1507
40. Djärv T, Lagergren P (2011) Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. Eur J Cancer 47:530-535
41. Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M, Consortium G (2010) I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 19:1419-1427